Sarah B Puryear1,2, Laura B Balzer3, James Ayieko4, Dalsone Kwarisiima5, Judith A Hahn1, Edwin D Charlebois1,2, Tamara D Clark1, Craig R Cohen6, Elizabeth A Bukusi4, Moses R Kamya5,7, Maya L Petersen8, Diane V Havlir1, Gabriel Chamie1. 1. Division of HIV, Infectious Diseases and Global Medicine. 2. Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, California. 3. Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts, Amherst, USA. 4. Kenya Medical Research Institute, Kisumu, Kenya. 5. Infectious Diseases Research Collaboration, Kampala, Uganda. 6. Department of Obstetrics, Gynecology & Reproductive Sciences, University of California San Francisco, San Francisco, California, USA. 7. Makerere University College of Health Sciences, Kampala, Uganda. 8. Divisions of Biostatistics and Epidemiology, School of Public Health, University of California Berkeley, Berkeley, California, USA.
Abstract
OBJECTIVE: To assess the impact of alcohol use on HIV care cascade outcomes. DESIGN: Cross-sectional analyses. METHODS: We evaluated HIV care cascade outcomes and alcohol use in adults (≥15 years) during baseline (2013--2014) population-based HIV testing in 28 Kenyan and Ugandan communities. 'Alcohol use' included any current use and was stratified by Alcohol Use Disorders Identification Test-Concise (AUDIT-C) scores: nonhazardous/low (1--3 men/1--2 women), hazardous/medium (4--5 men/3--5 women), hazardous/high (6--7), hazardous/very-high (8--12). We estimated cascade outcomes and relative risks associated with each drinking level using targeted maximum likelihood estimation, adjusting for confounding and missing measures. RESULTS: Among 118 923 adults, 10 268 (9%) tested HIV-positive. Of those, 10 067 (98%) completed alcohol screening: 1626 (16%) reported drinking, representing 7% of women (467/6499) and 33% of men (1 159/3568). Drinking levels were: low (48%), medium (34%), high (11%), very high (7%). Drinkers were less likely to be previously HIV diagnosed (58% [95% CI: 55--61%]) than nondrinkers [66% (95% CI: 65-67%); RR: 0.87 (95% CI: 0.83-0.92)]. If previously diagnosed, drinkers were less likely to be on ART [77% (95% CI: 73-80%)] than nondrinkers [83% (95% CI 82-84%); RR: 0.93 (95% CI: 0.89-0.97)]. If on ART, there was no association between alcohol use and viral suppression; however, very-high-level users were less likely to be suppressed [RR: 0.80 (95% CI: 0.68-0.94)] versus nondrinkers. On a population level, viral suppression was 38% (95% CI: 36-41%) among drinkers and 44% (95% CI: 43-45%) among nondrinkers [RR: 0.87 (95% CI 0.82-0.94)], an association seen at all drinking levels. CONCLUSION: Alcohol use was associated with lower viral suppression; this may be because of decreased HIV diagnosis and ART use.
OBJECTIVE: To assess the impact of alcohol use on HIV care cascade outcomes. DESIGN: Cross-sectional analyses. METHODS: We evaluated HIV care cascade outcomes and alcohol use in adults (≥15 years) during baseline (2013--2014) population-based HIV testing in 28 Kenyan and Ugandan communities. 'Alcohol use' included any current use and was stratified by Alcohol Use Disorders Identification Test-Concise (AUDIT-C) scores: nonhazardous/low (1--3 men/1--2 women), hazardous/medium (4--5 men/3--5 women), hazardous/high (6--7), hazardous/very-high (8--12). We estimated cascade outcomes and relative risks associated with each drinking level using targeted maximum likelihood estimation, adjusting for confounding and missing measures. RESULTS: Among 118 923 adults, 10 268 (9%) tested HIV-positive. Of those, 10 067 (98%) completed alcohol screening: 1626 (16%) reported drinking, representing 7% of women (467/6499) and 33% of men (1 159/3568). Drinking levels were: low (48%), medium (34%), high (11%), very high (7%). Drinkers were less likely to be previously HIV diagnosed (58% [95% CI: 55--61%]) than nondrinkers [66% (95% CI: 65-67%); RR: 0.87 (95% CI: 0.83-0.92)]. If previously diagnosed, drinkers were less likely to be on ART [77% (95% CI: 73-80%)] than nondrinkers [83% (95% CI 82-84%); RR: 0.93 (95% CI: 0.89-0.97)]. If on ART, there was no association between alcohol use and viral suppression; however, very-high-level users were less likely to be suppressed [RR: 0.80 (95% CI: 0.68-0.94)] versus nondrinkers. On a population level, viral suppression was 38% (95% CI: 36-41%) among drinkers and 44% (95% CI: 43-45%) among nondrinkers [RR: 0.87 (95% CI 0.82-0.94)], an association seen at all drinking levels. CONCLUSION: Alcohol use was associated with lower viral suppression; this may be because of decreased HIV diagnosis and ART use.
Authors: R Scott Braithwaite; Kathleen A McGinnis; Joseph Conigliaro; Stephen A Maisto; Stephen Crystal; Nancy Day; Robert L Cook; Adam Gordon; Michael W Bridges; Jason F S Seiler; Amy C Justice Journal: Alcohol Clin Exp Res Date: 2005-07 Impact factor: 3.455
Authors: Diane V Havlir; Laura B Balzer; Edwin D Charlebois; Tamara D Clark; Dalsone Kwarisiima; James Ayieko; Jane Kabami; Norton Sang; Teri Liegler; Gabriel Chamie; Carol S Camlin; Vivek Jain; Kevin Kadede; Mucunguzi Atukunda; Theodore Ruel; Starley B Shade; Emmanuel Ssemmondo; Dathan M Byonanebye; Florence Mwangwa; Asiphas Owaraganise; Winter Olilo; Douglas Black; Katherine Snyman; Rachel Burger; Monica Getahun; Jackson Achando; Benard Awuonda; Hellen Nakato; Joel Kironde; Samuel Okiror; Harsha Thirumurthy; Catherine Koss; Lillian Brown; Carina Marquez; Joshua Schwab; Geoff Lavoy; Albert Plenty; Erick Mugoma Wafula; Patrick Omanya; Yea-Hung Chen; James F Rooney; Melanie Bacon; Mark van der Laan; Craig R Cohen; Elizabeth Bukusi; Moses R Kamya; Maya Petersen Journal: N Engl J Med Date: 2019-07-18 Impact factor: 91.245
Authors: Robert Gross; Scarlett L Bellamy; Bakgaki Ratshaa; Xiaoyan Han; Andrew P Steenhoff; Mosepele Mosepele; Gregory P Bisson Journal: Addiction Date: 2016-09-07 Impact factor: 6.526
Authors: Panagiotis Vagenas; Kaysia T Ludford; Pedro Gonzales; Jesus Peinado; Cesar Cabezas; Fernando Gonzales; Javier R Lama; Jorge Sanchez; Frederick L Altice Journal: AIDS Behav Date: 2014-01
Authors: Emily C Williams; Kathleen A McGinnis; E Jennifer Edelman; Theresa E Matson; Adam J Gordon; Brandon D L Marshall; Kendall J Bryant; Anna D Rubinsky; Gwen T Lapham; Derek D Satre; Julie E Richards; Sheryl L Catz; David A Fiellin; Amy C Justice; Katharine A Bradley Journal: AIDS Behav Date: 2019-01
Authors: Maya Petersen; Laura Balzer; Dalsone Kwarsiima; Norton Sang; Gabriel Chamie; James Ayieko; Jane Kabami; Asiphas Owaraganise; Teri Liegler; Florence Mwangwa; Kevin Kadede; Vivek Jain; Albert Plenty; Lillian Brown; Geoff Lavoy; Joshua Schwab; Douglas Black; Mark van der Laan; Elizabeth A Bukusi; Craig R Cohen; Tamara D Clark; Edwin Charlebois; Moses Kamya; Diane Havlir Journal: JAMA Date: 2017-06-06 Impact factor: 56.272
Authors: Jürgen Rehm; Gerhard E Gmel; Gerrit Gmel; Omer S M Hasan; Sameer Imtiaz; Svetlana Popova; Charlotte Probst; Michael Roerecke; Robin Room; Andriy V Samokhvalov; Kevin D Shield; Paul A Shuper Journal: Addiction Date: 2017-02-20 Impact factor: 6.526
Authors: Gabriel Chamie; Matthew D Hickey; Dalsone Kwarisiima; James Ayieko; Moses R Kamya; Diane V Havlir Journal: Curr HIV/AIDS Rep Date: 2020-08 Impact factor: 5.071
Authors: Uzaib Saya; Sarah MacCarthy; Barbara Mukasa; Peter Wabukala; Lillian Lunkuse; Zachary Wagner; Sebastian Linnemayr Journal: BMC Public Health Date: 2022-05-27 Impact factor: 4.135
Authors: Derek D Satre; Tory Levine-Hall; Stacy A Sterling; Kelly C Young-Wolff; Jennifer O Lam; Stacey Alexeeff; J Carlo Hojilla; Andrew Williams; Amy C Justice; Jonathan Sterne; Matthias Cavassini; Kendall J Bryant; Emily C Williams; Michael A Horberg; Paul Volberding; Constance Weisner; Michael J Silverberg Journal: Drug Alcohol Depend Date: 2021-01-08 Impact factor: 4.492
Authors: Amanda P Miller; Eileen V Pitpitan; Susan M Kiene; Anita Raj; Sonia Jain; María Luisa Zúñiga; Dorean Nabulaku; Fred Nalugoda; Robert Ssekubugu; Betty Nantume; Godfrey Kigozi; Nelson K Sewankambo; Joseph Kagaayi; Steven J Reynolds; Kate Grabowski; Maria Wawer; Jennifer A Wagman Journal: Drug Alcohol Depend Date: 2021-08-28 Impact factor: 4.492
Authors: Ariadna Capasso; Jennifer L Brown; Polina Safonova; Nikolay Belyakov; Vadim Rassokhin; Ralph J DiClemente Journal: AIDS Behav Date: 2021-05-20